SBLOF (Shin Nippon Biomedical Laboratories) Institutional Ownership: 13.39% (As of Jul. 04, 2026)


SBLOF Shin Nippon Biomedical Laboratories Ltd SBLOF
74 GF Score
Price $9.16
GF Value $13.86
! 5 Warning Signs
View Full Analysis

What is Shin Nippon Biomedical Laboratories Institutional Ownership?

Shin Nippon Biomedical Laboratories SBLOF -2.13% 74 Institutional Ownership is 13.39% as of Jul. 04, 2026. GuruFocus rates SBLOF with a GF Score™ of 74/100 and a GF Value™ of $13.86. The stock has 5 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Shin Nippon Biomedical Laboratories's institutional ownership is 13.39%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Shin Nippon Biomedical Laboratories's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Shin Nippon Biomedical Laboratories's Float Percentage Of Total Shares Outstanding is 0.00%.

Shin Nippon Biomedical Laboratories Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Shin Nippon Biomedical Laboratories's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shin Nippon Biomedical Laboratories Institutional Ownership Chart

Shin Nippon Biomedical Laboratories Historical Data

The historical data trend for Shin Nippon Biomedical Laboratories can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 11.72 11.28 11.42 11.40 11.38 11.78 11.51 11.56 11.65 11.42
SBLOF
74GF Score
Shin Nippon Biomedical Laboratories Ltd SBLOF
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shin Nippon Biomedical Laboratories Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 13.39% mean?
Shin Nippon Biomedical Laboratories (SBLOF) has a Institutional Ownership of 13.39% as of Jul. 04, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Shin Nippon Biomedical Laboratories and its competitors.
Is Shin Nippon Biomedical Laboratories' Institutional Ownership too high?
Shin Nippon Biomedical Laboratories' current Institutional Ownership is 13.39%. Overall, Shin Nippon Biomedical Laboratories has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Shin Nippon Biomedical Laboratories' Institutional Ownership compare to TMO and DHR?
Shin Nippon Biomedical Laboratories' Institutional Ownership of 13.39% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Diagnostics & Research company?
A good Institutional Ownership depends on the Medical Diagnostics & Research industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Shin Nippon Biomedical Laboratories and its competitors. Shin Nippon Biomedical Laboratories's current Institutional Ownership is 13.39%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shin Nippon Biomedical Laboratories stock overvalued right now?
Shin Nippon Biomedical Laboratories (SBLOF) has a current Institutional Ownership of 13.39%. The stock's GF Value™ is $13.86, compared to a current price of $9.16 — trading 33.9% below its estimated fair value. The current Institutional Ownership is 13.39%. Shin Nippon Biomedical Laboratories' overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Shin Nippon Biomedical Laboratories (SBLOF), the current Institutional Ownership is 13.39% as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shin Nippon Biomedical Laboratories (SBLOF) Overvalued in 2026?

Based on GuruFocus' analysis, Shin Nippon Biomedical Laboratories stock appears to be undervalued. The current stock price of $9.16 is trading 33.9% below its estimated GF Value™ of $13.86.

Key valuation signals for SBLOF:

  • Institutional Ownership: 13.39%
  • GF Value™: $13.86 vs. price of $9.16 (33.9% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the SBLOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shin Nippon Biomedical Laboratories Business Description

Other Exchanges 2395:JapanYB3:Germany
Address 8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
74GF Score

Get the complete analysis for SBLOF

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.16
Price
$13.86
GF Value